Frontier Wealth Management LLC Checkpoint Therapeutics, Inc. Transaction History

Frontier Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$2.5 - $3.53 $884,950 - $1.25 Million	-353,980 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$1.62 - $4.24 $573,447 - $1.5 Million	353,980 New	353,980 $949,000
Q2 2019 Aug 16, 2019	SELL	$2.75 - $5.0 $580,250 - $1.06 Million	-211,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.01 - $4.01 $82,409 - $164,410	41,000 Added 24.12%	211,000 $603,000
Q3 2018 Nov 14, 2018	BUY	$2.46 - $4.72 $49,200 - $94,400	20,000 Added 13.33%	170,000 $608,000
Q2 2018 Aug 14, 2018	BUY	$2.45 - $4.39 $122,500 - $219,499	50,000 Added 50.0%	150,000 $447,000
Q1 2018 May 15, 2018	BUY	$3.24 - $5.6 $324,000 - $560,000	100,000 New	100,000 $439,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $272M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Frontier Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Wealth Management LLC with notifications on news.